Deferred Tax Assets, Gross in USD of ABVC BIOPHARMA, INC. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ABVC BIOPHARMA, INC. quarterly Deferred Tax Assets, Gross history and change rate from Q3 2011 to Q3 2025.
  • ABVC BIOPHARMA, INC. Deferred Tax Assets, Gross for the quarter ending 30 Sep 2025 was $6.91M, a 10.1% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.91M +$633K +10.1% 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 $6.76M +$519K +8.32% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $6.58M +$331K +5.3% 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $6.39M +$659K +11.5% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 $6.27M 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $6.24M 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $6.25M 31 Mar 2024 10-Q 17 May 2024
Q4 2023 $5.73M -$845K -12.8% 31 Dec 2023 10-K 15 Apr 2025
Q4 2022 $6.58M +$5.59M +570% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $1.01M 30 Sep 2022 10-Q 14 Nov 2022
Q4 2021 $982K 31 Dec 2021 10-Q 14 Nov 2022
Q4 2015 $25.7K +$22K 31 Dec 2015 10-Q 23 Feb 2016
Q3 2015 $29.1K +$25.6K 30 Sep 2015 10-K 27 Nov 2015
Q2 2015 $8.38K 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $3.89K 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 $3.76K* +$3.76K 31 Dec 2014 10-Q 23 Feb 2016
Q3 2014 $3.49K* +$3.49K 30 Sep 2014 10-K 27 Nov 2015
Q4 2013 $0 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 $0 -$1.94M -100% 30 Sep 2013 10-K 17 Apr 2015
Q3 2012 $1.94M -$2.68M -58.1% 30 Sep 2012 10-K 16 Apr 2015
Q3 2011 $4.62M 30 Sep 2011 10-K 15 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.